Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study (STOP-NPT3)
Cardiopulmonary Disease, Smoking Cessation, Inpatient
About this trial
This is an interventional treatment trial for Cardiopulmonary Disease
Eligibility Criteria
Inclusion Criteria: Admitted to Baystate Medical Center in Springfield, MA with a cardiac or pulmonary disease diagnosis will be eligible to participate in this trial. Patients who smoke cigarettes Speak English We will include any patients with the following diagnoses or procedures from Baystate Medical Center in Springfield, MA: myocardial infarction coronary artery bypass grafting surgery heart valve surgery percutaneous coronary intervention (PCI) acute coronary syndrome heart failure chronic obstructive pulmonary disease (COPD) asthma exacerbation. Exclusion Criteria: We will exclude pregnant or nursing women, patients with current suicidal ideation, planned discharge to hospice or expected survival <6 months, or concurrent use of daily smoked marijuana, because this can increase exhaled carbon monoxide levels, which would confound biochemical confirmation.
Sites / Locations
- Baystate Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Enhanced usual care (EUC)
Personalized Care: Nurse Practitioner led Tobacco Treatment Team (NPT3)
The investigators will administer the enhanced usual care intervention to randomized patients.
The investigators will administer the personalized care NPT3 intervention to randomized patients.